2026-2027 | On-Demand Session | Neurobiology of Addiction | August 2026
Availability
On-Demand
Expires on Jun 30, 2028
Cost
$0.00
Included with ACAAM membership. Join ACAAM to access this and other educational offerings.

ACAAM Members, select "Get Started" to register for this session.

This session provides a focused overview of the neurobiological foundations of addiction, including the brain mechanisms that drive substance use, reinforcement, craving, and the development of substance use disorders. Aligned with the ACAAM National Addiction Medicine Didactic Curriculum and ABPM content areas, the session explores major theories of addiction, core neurobiological pathways, and the relationship between addiction neuroscience and clinical manifestations of substance use disorders.

What This Covers

• Key theories of addiction, including the dopamine hypothesis, incentive sensitization, and allostasis
• Core neurobiological concepts underlying reward, motivation, reinforcement, and learning
• The distinction between “liking,” “wanting,” and learning in addiction-related behavior
• The effects of substance use on brain function and the development of substance use disorders
• Neuroadaptations that contribute to craving, compulsive substance use, and relapse risk
• The relationship between neurobiology and clinical manifestations of addiction
• Challenges in translating neurobiological concepts into effective clinical treatment and practice

How This Resource Is Used

This session is designed for on-demand learning, focused content review, and board preparation. It may be used to reinforce foundational addiction medicine concepts, supplement fellowship training, or support preparation for addiction medicine certification examinations. Learners can engage with specific topic areas independently or complete the full session as part of a structured study plan.

Daniel J. Roche, PhD

Dr. Roche is an Assistant Professor of Psychiatry at the University of Maryland School of Medicine and a researcher at the Maryland Psychiatric Research Center. His work focuses on the neurobiology of addiction, including human laboratory models, behavioral pharmacology, and the development of novel treatments for substance use disorders. He studies the mechanisms underlying substance use to translate neuroscience findings into clinical applications and improve treatment approaches for individuals with addiction.

To support a meaningful learning experience and recognize your participation:

  • After viewing a minimum of 50% of the session, the evaluation will become available
  • We encourage you to complete the evaluation to reflect on the content and provide valuable feedback
  • Upon completion, a Certificate of Participation will be issued for your records
Powered By